BRUKER CORPORATION Excess Tax Benefit from Share-based Compensation, Financing Activities
BRUKER CORPORATION (BRKR) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $1.20 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2019-03-01
- BRUKER CORPORATION excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-12-31 was $900.00K.
- BRUKER CORPORATION excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-09-30 was $0.00.
- BRUKER CORPORATION excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-12-31 was $0.00.
- BRUKER CORPORATION excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-09-30 was $0.00.
- BRUKER CORPORATION excess tax benefit from share-based compensation, financing activities for fiscal 2016 was $1.20M, a 45.45% decline from fiscal 2015.
- BRUKER CORPORATION excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $2.20M.
- BRUKER CORPORATION excess tax benefit from share-based compensation, financing activities for fiscal 2011 was $200.00K, a 33.33% decline from fiscal 2010.
- BRUKER CORPORATION excess tax benefit from share-based compensation, financing activities for fiscal 2010 was $300.00K, a 50.00% decline from fiscal 2009.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|---|---|
| 2016-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $900.00K derived: sum of 2 quarters · filed 2019-03-01 | $1.20M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $300.00K 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $300.00K 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $2.20M 10-K · filed 2018-03-16 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $2.20M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $2.20M 10-Q · filed 2016-08-05 | ||
| 2015-03-31 | $2.20M 10-Q · filed 2016-05-06 | |||
| 2011-12-31 | $200.00K 10-K · filed 2014-02-27 | |||
| 2010-12-31 | $300.00K 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $600.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |